{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:32:47Z","timestamp":1790710367724,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003032.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T00:00:00Z","timestamp":1487030400000}}],"reference-count":37,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003032.pub3","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T15:59:11Z","timestamp":1487087951000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents"],"prefix":"10.1002","author":[{"given":"Francesco","family":"Brigo","sequence":"first","affiliation":[{"name":"University of Verona; Department of Neuroscience, Biomedicine and Movement; P.le L.A. Scuro, 10 Verona Verona Italy 37134"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley C","family":"Igwe","sequence":"additional","affiliation":[{"name":"Federal Teaching Hospital; Department of Neuropsychiatry; Abakaliki Ebonyi State Nigeria 48000"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,14]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD003032.pub3-BIB0001|cit1","first-page":"277","article-title":"Comparative study of sodium valproate and lamotrigine as monotherapy in the management of typical absence seizures","volume":"46","author":"Basu","year":"2005","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD003032.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1469-8749.1982.tb13703.x","article-title":"Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal)","volume":"24","author":"Callaghan","year":"1982","journal-title":"Developmental Medicine and Clinical Neurology"},{"issue":"9","key":"10.1002\/14651858.CD003032.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.0013-9580.2004.40903.x","article-title":"Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study","volume":"45","author":"Coppola","year":"2004","journal-title":"Epilepsia"},{"issue":"6","key":"10.1002\/14651858.CD003032.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.braindev.2003.09.008","article-title":"Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial","volume":"26","author":"Coppola","year":"2004","journal-title":"Brain and Development"},{"issue":"7","key":"10.1002\/14651858.CD003032.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","article-title":"Lamictal (lamotrigine) monotherapy for typical absence seizures in children","volume":"40","author":"Frank","year":"1999","journal-title":"Epilepsia"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD003032.pub3-BIB0006|cit6","first-page":"320","article-title":"Childhood absence seizures: onset of treatment efficacy with lamotrigine","volume":"45","author":"Frank","year":"2004","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD003032.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/epi.12028","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD003032.pub3-BIB0008|cit8","first-page":"653","article-title":"Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children","volume":"11","author":"Huang","year":"2009","journal-title":"Zhongguo Dangdai Erke Zazhi"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0009|cit9","unstructured":"Martinovic Z Comparison of ethosuximide with sodium valproate as monotherapies of absence seizures Advances in Epileptology: XIVth Epilepsy International Symposium New York Raven Press 1983 301 5"},{"issue":"2","key":"10.1002\/14651858.CD003032.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1212\/WNL.32.2.157","article-title":"Valproic acid versus ethosuximide in the treatment of absence seizures","volume":"32","author":"Sato","year":"1982","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003032.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-3476(95)70047-1","article-title":"Lamotrigine for the treatment of epilepsy in childhood","volume":"127","author":"Besag","year":"1995","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0387-7604(99)00023-6","article-title":"Lamotrigine in typical absence epilepsy","volume":"21","author":"Buoni","year":"1999","journal-title":"Brain and Development"},{"issue":"June","key":"10.1002\/14651858.CD003032.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archpedi.1982.03970420050011","article-title":"Valproic acid in the treatment of intractable absence seizures in children: a single-blind clinical and quantitative EEG study","volume":"136","author":"Erenberg","year":"1982","journal-title":"American Journal of Diseases of Children"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1600-0404.1995.tb00434.x","article-title":"Lamotrigine as an add-on drug in typical absence seizures","volume":"91","author":"Ferrie","year":"1995","journal-title":"Acta Neurologica Scandinavica"},{"issue":"82","key":"10.1002\/14651858.CD003032.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eplepsyres.2008.07.016","article-title":"Lamotrigine monotherapy for newly diagnosed typical absence seizures in children","volume":"2","author":"Holmes","year":"2008","journal-title":"Epilepsy Research"},{"issue":"17","key":"10.1002\/14651858.CD003032.pub3-BIB0016|cit16","first-page":"1174","article-title":"Efficacy and safety of the combined therapy of valproic acid and lamotrigine for epileptics","volume":"92","author":"Kang","year":"2012","journal-title":"Chung-Hua i Hsueh Tsa Chih"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3923\/ijp.2009.313.318","article-title":"A randomized open-label comparison of lamotrigine and valproate in patients with juvenile myoclonic epilepsy","volume":"5","author":"Nejad","year":"2009","journal-title":"International Journal of Pharmacology"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0404.1983.tb01534.x","article-title":"Absence seizures: valproate or ethosuximide?","volume":"Suppl 97","author":"Santavuori","year":"1983","journal-title":"Acta Neurologica Scandinavica Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD003032.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1528-1157.1994.tb02445.x","article-title":"Lamotrigine in treatment of 120 children with epilepsy","volume":"35","author":"Schlumberger","year":"1994","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0020|cit20","first-page":"470","article-title":"A double-blind comparative trial of sodium dipropylacetate and ethosuximide in epilepsy in children","volume":"82","author":"Suzuki","year":"1972","journal-title":"Medical Progress (Japan)"},{"issue":"4","key":"10.1002\/14651858.CD003032.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0022|cit22","first-page":"547","article-title":"Childhood absence epilepsy and juvenile absence epilepsy","volume-title":"The Treatment of Epilepsy Principles and Practice","author":"Berkovic","year":"1993"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003032.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1111\/j.1528-1157.1987.tb05766.x","article-title":"Valproate monotherapy in the management of generalized and partial seizures","volume":"28","author":"Chadwick","year":"1987","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0024|cit24","unstructured":"Christe W Valproate in juvenile myoclonic epilepsy Fourth International Symposium on Sodium Valproate and Epilepsy London Royal Society of Medicine Services 1989"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0025|cit25","unstructured":"Duncan JS Treatment strategies for typical absences and related epileptic syndromes Typical absences and related epileptic syndromes London Churchill Communications Europe 1995"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0026|cit26","first-page":"658","article-title":"Succinimides Adverse effects","volume-title":"Antiepileptic Drugs","author":"Glauser","year":"2002"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0029|cit29","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from http:\/\/handbook.cochrane.org\/"},{"issue":"7","key":"10.1002\/14651858.CD003032.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jmg.37.7.489","article-title":"A clinical study of 57 children with fetal anticonvulsant syndromes","volume":"37","author":"Moore","year":"2000","journal-title":"Journal of Medical Genetics"},{"issue":"5","key":"10.1002\/14651858.CD003032.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00128072-200103050-00006","article-title":"Treatment of typical absence seizures and related epileptic syndromes","volume":"3","author":"Panayiotopoulos","year":"2001","journal-title":"Paediatric Drugs"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2007-984446","article-title":"Is ethosuximide a risk factor for generalised tonic-clonic seizures in absence epilepsy?","volume":"38","author":"Schmitt","year":"2007","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1002\/14651858.CD003032.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5698\/1535-7511-13.3.135","article-title":"The current state of absence epilepsy: can we have your attention?","volume":"13","author":"Tenney","year":"2013","journal-title":"Epilepsy Currents"},{"key":"10.1002\/14651858.CD003032.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.seizure.2014.12.001","article-title":"Risk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysis","volume":"25","author":"Wang","year":"2015","journal-title":"Seizure"},{"issue":"3","key":"10.1002\/14651858.CD003032.pub3-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003032","article-title":"Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents","author":"EB","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003032.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.seizure.2004.12.003","article-title":"A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine","volume":"14","author":"Posner","year":"2005","journal-title":"Seizure"},{"issue":"4","key":"10.1002\/14651858.CD003032.pub3-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003032.pub2","article-title":"Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents","author":"Posner","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003032.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003032.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T13:26:29Z","timestamp":1719062789000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003032.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,14]]},"references-count":37,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003032.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD003032.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,14]]}}}